Skip to main content
. Author manuscript; available in PMC: 2017 Sep 22.
Published in final edited form as: Qual Life Res. 2011 Sep 17;21(6):1021–1030. doi: 10.1007/s11136-011-0011-8

Table 1.

Demographics of participants in sorting procedure (Objective 1) and validation study (Objective 2)

Sorting procedure (Objective 1)
Participants (N = 46)		 Validation study (Objective 2)
Participants (N = 231)
Age (years) 54.1 ± 9.3 53.6 ± 10.8
Disease duration (years) 14.1 ± 8.2 16.3 ± 9.5
 Female 37 (80.4) 191 (82.7)
Fatigue (0–10 scale)
 None (0) 2 (4.3) 6 (2.6)
 Mild(1) 0 (0) 12 (5.2)
 Moderate (2–4) 5 (10.8) 58 (25.1)
 Severe (5–10) 39 (84.8) 155 (67.1)
Disease severity (EDSS group)
 Mild (0–4.0) N/A 83 (35.9)
 Moderate (4.5–7.5) N/A 104 (45.0)
 Severe (8.0–9.5) N/A 44 (19.1)